» Articles » PMID: 26894994

Identification and Validation of Housekeeping Genes for Gene Expression Analysis of Cancer Stem Cells

Overview
Journal PLoS One
Date 2016 Feb 20
PMID 26894994
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The characterization of cancer stem cell (CSC) subpopulation, through the comparison of the gene expression signature in respect to the native cancer cells, is particularly important for the identification of novel and more effective anticancer strategies. However, CSC have peculiar characteristics in terms of adhesion, growth, and metabolism that possibly implies a different modulation of the expression of the most commonly used housekeeping genes (HKG), like b-actin (ACTB). Although it is crucial to identify which are the most stable HKG genes to normalize the data derived from quantitative Real-Time PCR analysis to obtain robust and consistent results, an exhaustive validation of reference genes in CSC is still missing. Here, we isolated CSC spheres from different musculoskeletal sarcomas and carcinomas as a model to investigate on the stability of the mRNA expression of 15 commonly used HKG, in respect to the native cells. The selected genes were analysed for the variation coefficient and compared using the popular algorithms NormFinder and geNorm to evaluate stability ranking. As a result, we found that: 1) Tata Binding Protein (TBP), Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta polypeptide (YWHAZ), Peptidylprolyl isomerase A (PPIA), and Hydroxymethylbilane synthase (HMBS) are the most stable HKG for the comparison between CSC and native cells; 2) at least four reference genes should be considered for robust results; 3) the use of ACTB should not be recommended, 4) specific HKG should be considered for studies that are focused only on a specific tumor type, like sarcoma or carcinoma. Our results should be taken in consideration for all the studies of gene expression analysis of CSC, and will substantially contribute for future investigations aimed to identify novel anticancer therapy based on CSC targeting.

Citing Articles

Prostate cancer cells elevate glycolysis and G6PD in response to caffeic acid phenethyl ester-induced growth inhibition.

Lin T, Chen P, Lin C, Wang B, Kuo Y, Yeh C BMC Cancer. 2025; 25(1):95.

PMID: 39819475 PMC: 11737093. DOI: 10.1186/s12885-025-13477-6.


Magnolol derivatives as specific and noncytotoxic inhibitors of breast cancer resistance protein (BCRP/ABCG2).

da Silva Zanzarini I, Henrique Kita D, Scheiffer G, Karoline Dos Santos K, de Paula Dutra J, Augusto Pastore M Bioorg Chem. 2024; 146:107283.

PMID: 38513324 PMC: 11069345. DOI: 10.1016/j.bioorg.2024.107283.


Validation of Endogenous Control Genes by Real-Time Quantitative Reverse Transcriptase Polymerase Chain Reaction for Acute Leukemia Gene Expression Studies.

DE Pinho Pessoa F, Viana V, de Oliveira M, Dias Nogueira B, Ribeiro R, DE Sousa Oliveira D Genes (Basel). 2024; 15(2).

PMID: 38397141 PMC: 10887733. DOI: 10.3390/genes15020151.


Structural and molecular characterization of lopinavir and ivermectin as breast cancer resistance protein (BCRP/ABCG2) inhibitors.

de Paula Dutra J, Scheiffer G, Kronenberger T, Gomes L, Zanzarini I, Karoline Dos Santos K EXCLI J. 2024; 22:1155-1172.

PMID: 38204967 PMC: 10776880. DOI: 10.17179/excli2023-6427.


Endogenous expression of inactive lysine deacetylases reveals deacetylation-dependent cellular mechanisms.

Toro T, Skripnikova E, Bornes K, Zhang K, Watt T PLoS One. 2023; 18(9):e0291779.

PMID: 37721967 PMC: 10506724. DOI: 10.1371/journal.pone.0291779.


References
1.
Siclari V, Qin L . Targeting the osteosarcoma cancer stem cell. J Orthop Surg Res. 2010; 5:78. PMC: 2988747. DOI: 10.1186/1749-799X-5-78. View

2.
Oktem G, Bilir A, Uslu R, Inan S, Demiray S, Atmaca H . Expression profiling of stem cell signaling alters with spheroid formation in CD133/CD44 prostate cancer stem cells. Oncol Lett. 2014; 7(6):2103-2109. PMC: 4049671. DOI: 10.3892/ol.2014.1992. View

3.
Salerno M, Avnet S, Bonuccelli G, Eramo A, De Maria R, Gambarotti M . Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas. Int J Oncol. 2013; 43(1):95-102. DOI: 10.3892/ijo.2013.1927. View

4.
Mueller M, Hermann P, Heeschen C . Cancer stem cells as new therapeutic target to prevent tumour progression and metastasis. Front Biosci (Elite Ed). 2009; 2(2):602-13. DOI: 10.2741/e117. View

5.
Willems E, Mateizel I, Kemp C, Cauffman G, Sermon K, Leyns L . Selection of reference genes in mouse embryos and in differentiating human and mouse ES cells. Int J Dev Biol. 2006; 50(7):627-35. DOI: 10.1387/ijdb.052130ew. View